title: [Endogenous heparin-like syndrome: analysis of clinical observations].
abstract: One of the reasons for non-surgical bleeding is heparin-like syndrome (HLS), under which is understanded presence of heparin effect in the absence of it's exogenous application. The role of endogenous heparins perform glycosaminoglycans -- biologically active substances. HLS is accompanied by endothelium damage and discussed in the network of the systemic inflammatory response syndrome (SIRS). HLS is described in liver future, sepsis, pregnancy and a number of hemoblastosis. Hypocoagulation effect of endogenous heparin localizates in X coagulation factor. The main method of diagnosis - thromboelastography. The use of a specific heparin antidote - Protamine sulfate has not confirmed clinical efficacy. Priority direction in the therapy of - methods of "shunt hemostasis". In this paper, we present the analysis of observations of 4 patients with developed endogenous HLS. In 2 cases (combination of sepsis with hepatic failure in one patient and initial thrombophilia in other) HLS has been accompanied by massive bleeding (massive hemothoraxc with haemorrhagic shock, a massive intraoperative blood loss). For HLS relief in these cases was used prothrombine complex concentrate (PCC) (in the 1st case), recombinant VIIa factor (in the 2nd case). In other cases, HLS (in a patient with multiple myeloma and childbirth in the postpartum period), haemorrhagic syndrome was not so expressed, the treatment was carried out with FFP transfusion.
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Bulanov
authors.forename: K V
authors.initials: KV
authors.lastname: Iatskov
authors.forename: E M
authors.initials: EM
authors.lastname: Shulutko
authors.forename: T E
authors.initials: TE
authors.lastname: Glukhova
authors.forename: S A
authors.initials: SA
authors.lastname: Andreĭchenko
mesh_terms: D000328:Adult; D000368:Aged; D001778:Blood Coagulation Disorders / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D017809:Fatal Outcome; D005260:Female; D006025:Glycosaminoglycans / Q000097:blood; D006488:Hemostasis, Surgical / Q000379:methods*; D006493:Heparin / Q000097:blood*; D006801:Humans; D008297:Male; D012771:Shock, Hemorrhagic / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D013577:Syndrome; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D013916:Thrombelastography
chemical_list: D006025:Glycosaminoglycans; D006493:Heparin